INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,133 Cr | ₹1,794 Cr | ₹1,749 Cr | ₹1,758 Cr | ₹1,792 Cr |
What is the latest Total Liabilities ratio of INDSWIFT LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹1,133 Cr |
Mar2023 | ₹1,794 Cr |
Mar2022 | ₹1,749 Cr |
Mar2021 | ₹1,758 Cr |
Mar2020 | ₹1,792 Cr |
How is Total Liabilities of INDSWIFT LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,133 Cr | -36.84 | |
Mar2023 | ₹1,794 Cr | 2.59 | |
Mar2022 | ₹1,749 Cr | -0.52 | |
Mar2021 | ₹1,758 Cr | -1.89 | |
Mar2020 | ₹1,792 Cr | - |
Compare Total Liabilities of peers of INDSWIFT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDSWIFT LABORATORIES | ₹714.7 Cr | -0.1% | 4.6% | -24.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
INDSWIFT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | -0.1% |
4.6% |
-24.2% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses